BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 20138038)

  • 1. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
    Clemons NJ; Wang DH; Croagh D; Tikoo A; Fennell CM; Murone C; Scott AM; Watkins DN; Phillips WA
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(12):G1335-46. PubMed ID: 23064761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.
    Wang DH; Tiwari A; Kim ME; Clemons NJ; Regmi NL; Hodges WA; Berman DM; Montgomery EA; Watkins DN; Zhang X; Zhang Q; Jie C; Spechler SJ; Souza RF
    J Clin Invest; 2014 Sep; 124(9):3767-80. PubMed ID: 25083987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
    Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
    Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
    Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
    Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide could promote development of Barrett's esophagus by
    Fujiya T; Asanuma K; Koike T; Okata T; Saito M; Asano N; Imatani A; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G107-G116. PubMed ID: 34786954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Sonic hedgehog (SHH) and CDX2 in the columnar epithelium of the lower oesophagus.
    Yamanaka Y; Shiotani A; Fujimura Y; Ishii M; Fujita M; Matsumoto H; Tarumi K; Kamada T; Hata J; Haruma K
    Dig Liver Dis; 2011 Jan; 43(1):54-9. PubMed ID: 20619754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
    Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
    Souza RF
    J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
    Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
    Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
    Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models.
    Correia ACP; Straub D; Read M; Hoefnagel SJM; Romero-Pinedo S; Abadía-Molina AC; Clemons NJ; Wang K; Calpe S; Phillips W; Krishnadath KK
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1199-1217. PubMed ID: 36706916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
    Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.
    Zhang Q; Yu C; Peng S; Xu H; Wright E; Zhang X; Huo X; Cheng E; Pham TH; Asanuma K; Hatanpaa KJ; Rezai D; Wang DH; Sarode V; Melton S; Genta RM; Spechler SJ; Souza RF
    Gastroenterology; 2014 Feb; 146(2):461-72.e6. PubMed ID: 24120473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.